WidrichWC, The use of intraarterial lidocaine to control pain due to aortofemoral arteriography. Radiology1977; 124: 37–41.
2.
GordonIIWestcottJL, Intraarterial lidocaine: An effective analgesic for peripheral angiography. Radiology1977; 124: 43–5.
3.
GuthanerDF, Intraarterial analgesia in peripheral arteriography. Am J Roentgenol1977; 128: 737–9.
4.
EisenbergRL, Pain associated with peripheral angiography: Is lidocaine effective?Radiology1978; 127: 109–11.
5.
Ben-MenachemY.Paradoxic response to intraarterial lidocaine analgesia. Am J Roentgenol1978; 130: 360–1.
6.
AronsonJK, Cardiac glycosides and drugs used in dysrythmias. In: DukesMN, ed. Side effects of drugs annual 2. Amsterdam: Excerpta Medica, 1978: 158–65.
7.
SjoerdsmaA, Pheochromocytoma: Current concepts in diagnosis and treatment. Ann Intern Med1966; 65: 1302–26.
8.
BrayGA, Catecholamines — A symposium. Cal Med1972: 117: 32.
9.
EngelmanKSjoerdsmaA.Inhibition of catecholamine biosynthesis in man. Circ Res (Suppl.) 1966; 18, 19: 104–9.
10.
RobinsonRG, Childhood pheochromocytoma — Treatment with alpha methyl tyrosine for resistant hypertension. J Pediatr1977; 91: 143–7.
11.
EngelmanK, Biochemical and pharmacological effects of alpha methyl tyrosine in man. J Clin Invest1968; 47: 577–94.
12.
SjoerdsmaA, Inhibition of catecholamine synthesis in man with alpha methyl tyrosine, an inhibitor of tyrosine hydroxylase. Lancet1965; 2: 1092–4.
PyoralaK, Alpha methyl tyrosine in symptomatic treatment of patients with malignant pheochromocytoma. Ann Med Intern Fenn1968; 57: 65–73.
15.
JeavonsPClarkJ.Sodium valproate in treatment of epilepsy. Br Med J1974; 2: 584–6.
16.
JeavonsP, Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (‘Epilim’). Dev Med Child Neurol1977; 19: 9–25.
17.
HassanM, Sodium valproate in the treatment of resistant epilepsy. Acta Neurol Scand1976; 54: 209–18.
18.
GamstorpI.Sodium valproate in treatment of children with refractory epilepsy. In: PenryJ, ed. Epilepsy, the eighth international symposium. New York: Raven Press, 1977: 187–90.
19.
SteckJ. (Abbott Laboratories, Pharmaceutical Products Division). Letter to editors. July 16, 1979.